Published in J Lipid Res on January 01, 1989
C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ (1996) 3.61
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest (1990) 2.02
Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins. Am J Clin Nutr (2011) 1.62
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest (2008) 1.48
Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun (1989) 1.45
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest (1997) 1.45
HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol (2008) 1.40
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res (2008) 1.39
Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Circulation (2008) 1.38
Unraveling the complexities of the HDL lipidome. J Lipid Res (2013) 1.19
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res (2009) 1.16
LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest (2001) 1.14
Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect Immun (2005) 1.10
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol (2009) 1.07
Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun (2001) 1.03
Novel relationship of serum cholesterol with asthma and wheeze in the United States. J Allergy Clin Immunol (2009) 1.00
Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun (2003) 0.99
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry (2006) 0.99
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF. Proteome Sci (2011) 0.97
Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease. Cardiovasc J Afr (2010) 0.94
Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest (1994) 0.91
Chylomicrons enhance endotoxin excretion in bile. Infect Immun (1993) 0.90
Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element. Nucleic Acids Res (1994) 0.90
Distinctive biochemical changes in pulmonary tuberculosis and pneumonia. Arch Med Sci (2013) 0.90
Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J (1995) 0.88
Secretory phospholipase A2 induces dendritic cell maturation. Eur J Immunol (2004) 0.88
Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages. PLoS One (2008) 0.87
Significant association between Helicobacter pylori infection and serum C-reactive protein. Int J Med Sci (2008) 0.87
The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia. Eur J Dent (2008) 0.87
Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase. J Lipid Res (2011) 0.86
High-density lipoproteins and the immune system. J Lipids (2013) 0.85
Opposite regulation of the human apolipoprotein M gene by hepatocyte nuclear factor 1 and Jun transcription factors. J Biol Chem (2011) 0.85
Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis (2006) 0.84
Serum amyloid a truncations in type 2 diabetes mellitus. PLoS One (2015) 0.84
High density lipoproteins and atherosclerosis: emerging aspects. J Geriatr Cardiol (2012) 0.83
Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. J Lipid Res (2015) 0.83
A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem (2008) 0.80
Treating low high-density lipoprotein cholesterol: what is the evidence? Ther Adv Endocrinol Metab (2014) 0.79
Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci (2015) 0.79
SAA: a link between cholesterol efflux capacity and inflammation? J Lipid Res (2015) 0.79
The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate. J Ayurveda Integr Med (2013) 0.78
Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory. Interdiscip Perspect Infect Dis (2013) 0.78
Single lysophosphatidylcholine components exhibit adjuvant activities in vitro and in vivo. Clin Vaccine Immunol (2010) 0.78
Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells. Clin Exp Immunol (2007) 0.78
Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrol Dial Transplant (2013) 0.77
Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice. J Lipid Res (2016) 0.76
HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats. J Clin Exp Cardiolog (2011) 0.75
Lipid response patterns in acute phase paediatric Plasmodium falciparum malaria. Metabolomics (2017) 0.75
Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest (1991) 0.75
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure. J Atheroscler Thromb (2016) 0.75
The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study. BMC Infect Dis (2017) 0.75
Association of Serum Lipids and Obstructive Lung Disease in Hispanic/Latino Adults of Diverse Backgrounds. J Pulm Respir Med (2017) 0.75
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum (2001) 4.60
Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc Natl Acad Sci U S A (1990) 3.69
Rat intestinal microvillus membranes. Purification and biochemical characterization. Biochem J (1968) 3.66
T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J Biol Chem (1989) 2.50
Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract (1995) 2.31
Manpower in gastroenterology in the United States: a position paper of the Training and Education Committee of the AGA. Gastroenterology (1989) 1.38
Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol Immunol (1987) 1.27
Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol (1997) 1.23
Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease. Gastroenterology (1977) 1.21
Lymphocytes of small mammals: spontaneous transformation in culture to blastoids. Science (1965) 1.19
Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. J Lipid Res (1977) 1.18
Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS (2001) 1.11
Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol (1991) 1.08
Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein. Biochemistry (1989) 1.07
Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am J Physiol (1984) 1.05
A three-stage clinical trial design for rare disorders. Stat Med (2001) 1.04
Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine. J Immunol (1981) 1.03
Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol (1989) 1.02
Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur J Immunol (1995) 0.99
CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis (1995) 0.95
Isolation of a latent murine hepatitis virus from cultured mouse liver cells. Am J Gastroenterol (1972) 0.95
Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein. J Immunol (1982) 0.94
A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol (1994) 0.93
Minimal hepatic changes in rats fed alcohol and a high casein diet. Arch Pathol Lab Med (1976) 0.93
Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Clin Immunol Immunopathol (1988) 0.93
A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins. Protein Sci (1992) 0.90
Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor. Clin Exp Immunol (1982) 0.89
T-cell suppression and contrasuppression induced by histamine H2 and H1 receptor agonists, respectively. Proc Natl Acad Sci U S A (1982) 0.88
Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals. Cytometry (1997) 0.87
Hypogammaglobulinemia and anemia 18 years after thymoma resection. J Allergy Clin Immunol (1997) 0.86
Platelet activating factor: an inhibitor of neutrophil activation? Clin Exp Immunol (1981) 0.85
Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Dig Dis Sci (1995) 0.84
An appraisal of polystyrene-(ELISA) and nitrocellulose-based (ELIFA) enzyme immunoassay systems using monoclonal antibodies reactive toward antigenically distinct forms of human C-reactive protein. J Immunol Methods (1991) 0.84
Role of histamine in the regulation of cell-mediated immunity. Int Arch Allergy Appl Immunol (1981) 0.84
Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol (1989) 0.83
Absence of a stratum corneum antigen in disorders of epidermal cell proliferation: detection with an anti-ganglioside GM3 antibody. J Invest Dermatol (1989) 0.83
Prevention of erosive oesophagitis relapse with pantoprazole. Aliment Pharmacol Ther (2004) 0.83
Inhibition of neutrophil activation by alpha1-acid glycoprotein. Clin Exp Immunol (1984) 0.83
Cholestatic lipoproteins--their pathogenesis and significance. Gastroenterology (1982) 0.82
Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. Mol Immunol (1992) 0.82
Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Am J Gastroenterol (1996) 0.82
Isolation and characterization of lipoprotein of density less than 1.006 g/ml from rat hepatic lymph. J Lipid Res (1983) 0.82
Effect of 3-amino-1,2,4-triazole on histidine metabolism in algae. Plant Physiol (1966) 0.81
Identification of nascent high density lipoproteins containing arginine-rich protein in human plasma. Biochem Biophys Res Commun (1978) 0.81
Intestinal lipoproteins in the rat with D-(+)-galactosamine hepatitis. J Lipid Res (1983) 0.81
Lipid and lipoprotein abnormalities in alcoholic liver disease. Circulation (1981) 0.81
D-galactosamine hepatotoxicity. II. Mechanism of fatty liver production. Proc Soc Exp Biol Med (1971) 0.80
Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment. J Lipid Res (1982) 0.80
Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis. Metabolism (1982) 0.80
Blastoid transformation of rabbit and guinea pig peripheral lymphocytes by phytohemagglutinin. Proc Soc Exp Biol Med (1966) 0.79
Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury. Science (1975) 0.79
CD8+ lymphocytes in pregnancy and HIV infection: characterization of CD8+ subpopulations and CD8+ noncytotoxic antiviral activity. AIDS Res Hum Retroviruses (1999) 0.79
Lipoprotein metabolism in liver disease. Adv Intern Med (1980) 0.79
Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency. Scand J Clin Lab Invest Suppl (1978) 0.79
Intestinal lipid absorption: evidence for an intrinsic defect of chylomicron secretion by normal rat distal intestine. Lipids (1975) 0.79
Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery. J Lipid Res (1982) 0.79
Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species. Immunology (1992) 0.79
Inhibition of intestinal protein synthesis and lipid transport by ethionine. Biochim Biophys Acta (1966) 0.79
Correctable plasma lipoprotein abnormalities in infants with choledochal cysts. Pediatr Res (1985) 0.79
Accumulation of nascent lipoproteins in rat hepatic golgi during induction of fatty liver by orotic acid. Lab Invest (1977) 0.78
Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infection. J Immunol (1996) 0.78
Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway. J Immunol (1992) 0.78
Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat. J Lipid Res (1986) 0.78
Inflammation-induced changes in rabbit CRP and plasma lipoproteins. J Immunol (1983) 0.78
Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals. J Clin Immunol (1997) 0.78
Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study. Aliment Pharmacol Ther (1997) 0.78
The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine. J Lab Clin Med (1992) 0.78
Computerized rapid high resolution quantitative analysis of plasma lipoproteins based upon single vertical spin centrifugation. J Lipid Res (1982) 0.78
Genetic and molecular genetic studies of murine and human lupus. J Rheumatol Suppl (1987) 0.77
Pathogenesis of experimental viral hepatitis (second of two parts). N Engl J Med (1974) 0.77
Preferential binding and aggregation of rabbit C-reactive protein with arginine-rich proteins. Mol Immunol (1991) 0.77
Alterations in lipoprotein composition associated with galactosamine-induced rat liver injury. J Lipid Res (1982) 0.77
Release of beta-glucuronidase as a quantitative assay of murine viral hepatitis injury in cultured cells. Exp Mol Pathol (1971) 0.76
Ultrastructural features of regional differences in chylomicron secretion by rat intestine. Exp Mol Pathol (1977) 0.76
Clinical conference: alcoholic hepatitis. Gastroenterology (1978) 0.76
D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liver. Exp Mol Pathol (1976) 0.76
Lipoprotein disturbances in liver disease. Prog Liver Dis (1979) 0.75
Liver transplantation. New hope for many patients. Postgrad Med (1990) 0.75
Current status of liver transplantation. Hosp Pract (Off Ed) (1987) 0.75
Goals of therapy: aggressive or moderate acid suppression? Clin Ther (1986) 0.75
The role of lecithin:cholesterol acyltransferase deficiency in the apoprotein metabolism of alcoholic hepatitis. Scand J Clin Lab Invest Suppl (1978) 0.75
Lipoprotein abnormalities in primary biliary cirrhosis: information concerning control of plasma high density lipoprotein levels. Gastroenterology (1985) 0.75
Structure of the gastrointestinal tract as it relates to nutrient movement. Curr Concepts Nutr (1980) 0.75
Hepatic triglyceride lipase deficiency in liver disease. Lipids (1977) 0.75
Antigen-RNA complexes. Science (1966) 0.75
D-galactosamine hepatotoxocity. V. Role of free fatty acids in the pathogenesis of fatty liver. Exp Mol Pathol (1978) 0.75
Inhibition of hepatic triglyceride secretion and exogenous triglyceride clearance in the cholestatic rat. Atherosclerosis (1987) 0.75
Medical Grand Rounds. Alcoholic hepatitis. J Tenn Med Assoc (1982) 0.75
Microtubules--biological machines at the molecular level. Gastroenterology (1981) 0.75
Lipoprotein profiles in chronic alcoholics: use of high-density lipoprotein subspecies levels to differentiate subpopulations. Hepatology (1984) 0.75
Guidelines for training in gallstone lithotripsy. Ann Intern Med (1991) 0.75
Intact proteoglycan is a polyclonal activator of murine B-lymphocytes. Immunol Lett (1987) 0.75
The effect of essential fatty acid deficiency on eicosanoid production in the inflamed rat colonic mucosa. Prostaglandins Leukot Essent Fatty Acids (1990) 0.75
Effects of lithium on neutrophil metabolism in vitro and on neutrophil function during therapy. Adv Exp Med Biol (1980) 0.75
Clinical results of piezoelectric gallstone lithotripsy. Am Surg (1992) 0.75
Fever, diaphoresis, and jaundice in an alcoholic. Hosp Pract (Off Ed) (1984) 0.75
Acid, cytoprotection, and peptic ulcer. Introduction. Am J Med (1987) 0.75
Double-blind multicenter comparison of 1,200 mg. and 1,000 mg. cimetidine in hospitalized and ambulatory duodenal ulcer patients. Am J Gastroenterol (1981) 0.75
Plasma lipoprotein changes during abstinence in chronic alcoholics. Atherosclerosis (1984) 0.75